Coronavirus Update - 07th August 2020

We would like to take this opportunity to thank our clients and staff for their continued support over this period of restricted movement. 

We remain open for business as usual and have started welcoming limited numbers of visitors to site

We fully comply with all government guidance on minimising the risks of COVID-19 and have published our risk assessment here

Article: Continuous transformation of pharmaceutical manufacturing

"Continuous flow technology is particularly suitable for fast, challenging chemistries that are difficult to control."

This article explores the benefits of continuous flow chemistry in synthesising pharmaceutical products. Our CSO, Gareth Jenkins, and Head of Drug Substance, Paul Quigley, describe the recent advances in the area of continuous flow chemistry, including the development of modular systems and real-time analytics. The significant impact of this rapidly evolving technology is also explored, particularly its use in the production of personalised medicine. 

You can read the full article here on the Chemistry Knowledge Hub website




Discover how Arcinova can help

We provide a fully integrated approach to drug development, speak to our team and discover how we can help you fast forward to market.

GET IN TOUCH